相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic value of serum HE4 level in the management of endometrial cancer: A pilot study
Niveditha Rajadevan et al.
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2021)
Endometrial cancer: A systematic review of HE4, REM and REM-B
Manon Degez et al.
CLINICA CHIMICA ACTA (2021)
Comparison of the predictive performance of risk of malignancy indexes 1-4, HE4 and risk of malignancy algorithm in the triage of adnexal masses
Abha Hada et al.
JOURNAL OF OVARIAN RESEARCH (2020)
Ultrasound Features Improve Diagnostic Performance of Ovarian Cancer Predictors in Distinguishing Benign and Malignant Ovarian Tumors
Yong-ning Chen et al.
CURRENT MEDICAL SCIENCE (2020)
Meta-analysis of the diagnostic accuracy of HE4 for endometrial carcinoma
Jing Liu et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2020)
Discriminative value of CA-125, HE4, Risk of Malignancy Index II (RMI-II) and Risk of Malignancy Algorithm (ROMA) in the differential diagnosis of pelvic masses: conclusions from a referral Centre in Portugal
Angela Melo et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2018)
A multicenter clinical trial validating the performance of HE4, CA125, risk of ovarian malignancy algorithm and risk of malignancy index
Maria Lycke et al.
GYNECOLOGIC ONCOLOGY (2018)
Standard and optimal cut-off values of serum ca-125, HE4 and ROMA in preoperative prediction of ovarian cancer in Vietnam
Nguyen Vu Quoc Huy et al.
GYNECOLOGIC ONCOLOGY REPORTS (2018)
Diagnostic performance of human epididymis protein 4 compared to a combination of biophysical and biochemical markers to differentiate ovarian endometriosis from epithelial ovarian cancer in premenopausal women
Tanja Nikolova et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2017)
Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models: results from the EPIC cohort
Renee T. Fortner et al.
JOURNAL OF OVARIAN RESEARCH (2017)
Value of serum human epididymis secretory protein 4 as a marker for differential diagnosis of malignant and benign gynecological diseases of patients in southern China
Laisheng Li et al.
CLINICA CHIMICA ACTA (2016)
Modification of cut-off values for HE4, CA125 and the ROMA algorithm for early-stage epithelial ovarian cancer detection: Results from 1021 cases in South China
Ying Xu et al.
CLINICAL BIOCHEMISTRY (2016)
Diagnostic Performance of Risk of Ovarian Malignancy Algorithm Against CA125 and HE4 in Connection With Ovarian Cancer A Meta-analysis
Farshid Dayyani et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2016)
Diagnostic usefulness of the Risk of Ovarian Malignancy Algorithm using the electrochemiluminescence immunoassay for HE4 and the chemiluminescence microparticle immunoassay for CA125
Anita Chudecka-Glaz et al.
ONCOLOGY LETTERS (2016)
Preoperative HE4, CA125 and ROMA in the differential diagnosis of benign and malignant adnexal masses
Katarzyna M. Terlikowska et al.
JOURNAL OF OVARIAN RESEARCH (2016)
Epidemiology of epithelial ovarian cancer, a single institution-based study in India
Surendra Kumar Saini et al.
CLINICAL CANCER INVESTIGATION JOURNAL (2016)
The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer
Su Wei et al.
BIOMEDICAL REPORTS (2016)
Development of a multimarker assay for differential diagnosis of benign and malignant pelvic masses
Xinliang Chen et al.
CLINICA CHIMICA ACTA (2015)
Human epididymis protein 4: Factors of variation
Simona Ferraro et al.
CLINICA CHIMICA ACTA (2015)
Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms: Clinical correlates
John B. Liao et al.
GYNECOLOGIC ONCOLOGY (2015)
Comparison of HE4, CA125, and Risk of Ovarian Malignancy Algorithm in the Prediction of Ovarian Cancer in Korean Women
Hye Yon Cho et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2015)
A predictive model combining human epididymal protein 4 and radiologic features for the diagnosis of ovarian cancer
A. Stiekema et al.
GYNECOLOGIC ONCOLOGY (2014)
Accuracy of Serum Human Epididymis Protein 4 in Ovarian Cancer Diagnosis A Systematic Review and Meta-Analysis
Ana Cristina Lacerda Macedo et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)
Diagnostic accuracy of serum HE4, CA125 and ROMA in patients with ovarian cancer: a meta-analysis
Jiwen Wang et al.
TUMOR BIOLOGY (2014)
HE4, Ca125 and ROMA algorithm for differential diagnosis between benign gynaecological diseases and ovarian cancer
Blanca Ortiz-Munoz et al.
TUMOR BIOLOGY (2014)
A study of ovarian cancer biomarker amplification using ultrasound for early stage detection
Danhong Peng et al.
ULTRASONICS (2014)
Preoperative Evaluation of Risk of Ovarian Malignancy Algorithm Index in Prediction of Malignancy of Adnexal Masses
Farah Farzaneh et al.
IRANIAN RED CRESCENT MEDICAL JOURNAL (2014)
Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response
Elham O. Hamed et al.
DIAGNOSTIC PATHOLOGY (2013)
Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: Correlation with pathological outcome
M. T. Sandri et al.
GYNECOLOGIC ONCOLOGY (2013)
The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass
Karen K. L. Chan et al.
GYNECOLOGIC ONCOLOGY (2013)
Differentiating stage 1 epithelial ovarian cancer from benign ovarian tumours using a combination of tumour markers HE4, CA125, and CEA and patient's age
Srinivas Kondalsamy-Chennakesavan et al.
GYNECOLOGIC ONCOLOGY (2013)
The plasma concentration of VEGF, HE4 and CA125 as a new biomarkers panel in different stages and sub-types of epithelial ovarian tumors
Slawomir Lawicki et al.
JOURNAL OF OVARIAN RESEARCH (2013)
Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and ca125 in predicting epithelial ovarian cancer: A meta-analysis
Fake Li et al.
BMC CANCER (2012)
Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass
Mona Aarenstrup Karlsen et al.
GYNECOLOGIC ONCOLOGY (2012)
Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women
Kevin Holcomb et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2011)
Serum Human Epididymis Protein 4 and Risk for Ovarian Malignancy Algorithm as New Diagnostic and Prognostic Tools for Epithelial Ovarian Cancer Management
Elisabetta Bandiera et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
HE4 and epithelial ovarian cancer: Comparison and clinical evaluation of two immunoassays and a combination algorithm
Giuseppina Ruggeri et al.
CLINICA CHIMICA ACTA (2011)
Diagnostic performances of HE4 and CA125 for the detection of ovarian cancer from patients with various gynecologic and non-gynecologic diseases
Yongjung Park et al.
CLINICAL BIOCHEMISTRY (2011)
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases
Jose M. Escudero et al.
CLINICAL CHEMISTRY (2011)
The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?
Martina Montagnana et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2011)
HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases
Rafael Molina et al.
TUMOR BIOLOGY (2011)
Preoperative evaluation and triage of women with suspicious adnexal masses using risk of malignancy index
Christopher A. Enakpene et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2009)
The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
Richard G. Moore et al.
GYNECOLOGIC ONCOLOGY (2008)
Proteins with whey-aicidic-protein motifs and cancer
D Bouchard et al.
LANCET ONCOLOGY (2006)
分享论文
